Company: BIVIW
Filing Date: 2025-09-25
Form Type: DEF 14A
Source: 0001520138-25-000287
Chunk: 20

Company: BIOVIE INC.
Filing Date: 2025-09-25
Form: DEF 14A
Chunk 20
---
.

Nominating and Corporate Governance Committee

The members of the Nominating and Corporate Governance Committee are Amy
Chappell, Sigmund Rogich and Michael Sherman. Mr. Rogich has served as Chairman of the Nominating and Corporate Governance Committee since
August 2025.

The primary responsibilities of the Nominating and Corporate Governance
Committee include:

| ● | identifying, screening and reviewing                                                                                                      
 individuals qualified to serve as directors, consistent with criteria approved by the Board of Directors, and recommending to the Board   
 of Directors candidates for nomination for election at the annual meeting of stockholders or to fill vacancies on the Board of Directors; |

| ● | developing and recommending to the                                                       
 Board of Directors and overseeing implementation of our corporate governance guidelines; |

| ● | coordinating and overseeing the annual                                                                                               
 self-evaluation of the Board of Directors, its committees, individual directors and management in the governance of the company; and |

| ● | reviewing on a regular basis our overall                                  
 corporate governance and recommending improvements as and when necessary. |

| -12- |

The charter also provides that the Nominating and Corporate Governance
Committee may, in its sole discretion, retain or obtain the advice of, and terminate, any search firm to be used to identify director
candidates, and will be directly responsible for approving the search firm’s fees and other retention terms.

We have not formally established any specific, minimum qualifications that
must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director, the
Board of Directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional
reputation, independence, wisdom, and the ability to represent the best interests of our stockholders. Prior to our initial business combination,
holders of our public shares will not have the right to recommend director candidates for nomination to our Board of Directors.

Set forth below is information concerning the gender and demographic background
of each of our current directors, as self-identified and reported by each director. This information is being provided in accordance with
Nasdaq’s board diversity rules.

2025 Meetings and Attendance

During fiscal year 2025, the Board held seven meetings of the Board of
Directors, four meetings of the Audit Committee, two meetings of the Compensation Committee and one meeting of the Nominating and Corporate
Governance Committee. All directors attended at least 75% or more of the aggregate number of meetings of the Board of Directors and